-
Mashup Score: 0Innovative cancer researchers are using data-driven protocols to improve disease detection and treatment - AACR Annual Meeting News - 2 year(s) ago
Three technology innovators, including session chair Tina Hernandez-Boussard, PhD, MPH, discussed how data-driven learning systems can be applied to different cancers to improve patient symptoms, outcomes, and overall care during an Annual Meeting symposium.
Source: AACR Annual Meeting NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2International physician-scientists address global cancer burden - AACR Annual Meeting News - 2 year(s) ago
A panel of physician-scientists from the U.S. and sub-Saharan Africa discussed the challenges of global cancer care and opportunities to improve outcomes in lower- and middle-income countries during a symposium on the final day of the Annual Meeting. Sharmila Anandasabapathy, MD, moderated the session.
Source: AACR Annual Meeting NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Global Cancer Burden: Challenges and Opportunities for Innovation — @anandasabapathy, @ChemtaiMungo, @ChiteDoc, and Surbhi Grover addressed this topic in a symposium at #AACR23. Read a recap in AACR Annual Meeting News: https://t.co/XFrkyr3XAV https://t.co/1ebC8lgi6P
-
-
Mashup Score: 3Panel explores strategies to diversify participation in oncology clinical trials - AACR Annual Meeting News - 2 year(s) ago
An expert panel, including session co-chairs Luis A. Diaz, MD, and Folakemi Odedina, PhD, discussed strategies to overcome disparities in oncology clinical trials during the Minorities in Cancer Research Scientific Symposium.
Source: AACR Annual Meeting NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Innovation to Address Disparities in Oncology Clinical Trials — Luis A. Diaz, LeeAnn Bailey, @DrOdedina, and @drjay_allday addressed this topic in a Minorities in Cancer Research Scientific Symposium at #AACR23. Recap in AACR Annual Meeting News: https://t.co/3276gOtBaH #AACRMICR https://t.co/yExd82z6qI
-
-
Mashup Score: 2Researchers discuss efforts to speed drug approval process by rethinking phase I trials - AACR Annual Meeting News - 2 year(s) ago
Three experts discussed the evolution of phase I trials during an Annual Meeting symposium on Tuesday, April 18. “We must recognize that forward- and reverse-translation are complementary and phase I is the place to do it. The old linear model of moving forward and failing later is not serving us or our patients,” said Shivaani Kummar, MD.
Source: AACR Annual Meeting NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
⭐️Nice summary of all the talks on Future drug development @AACR #AACR23 meeting ! Wait for @asco #ASCO23 for more cutting edge Research updates. #PrecisionMedicine for the win @OncoAlert https://t.co/T0GNaqUdfU https://t.co/hnlQqsNbdg
-
-
Mashup Score: 0Researchers discuss efforts to speed drug approval process by rethinking phase I trials - AACR Annual Meeting News - 2 year(s) ago
Three experts discussed the evolution of phase I trials during an Annual Meeting symposium on Tuesday, April 18. “We must recognize that forward- and reverse-translation are complementary and phase I is the place to do it. The old linear model of moving forward and failing later is not serving us or our patients,” said Shivaani Kummar, MD.
Source: AACR Annual Meeting NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Future of Phase I Clinical Trials — AACR President-Elect Patricia M. LoRusso, Shivaani Kummar, and @VivekSubbiah addressed this topic during a symposium at #AACR23. Read a recap in AACR Annual Meeting News: https://t.co/QpoPyBGQO5 https://t.co/jE7qGifibh
-
-
Mashup Score: 0Next-generation cancer therapies will reshape cancer treatment in the coming years - AACR Annual Meeting News - 2 year(s) ago
Five leading researchers discussed new concepts in drug discovery, engineering, and delivery on the final day of the Annual Meeting. Evan A. Scott, PhD, reviewed the use of targeted nanocarriers for cell-selective cancer therapy.
Source: AACR Annual Meeting NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New Concepts in Drug Discovery and Engineering — @CochranLab, @AndreaKasinski, @drGregBowman, @ProfScottBME, and Puja Sapra, PhD, addressed this topic during a plenary session at #AACR23. Read a recap in AACR Annual Meeting News: https://t.co/FKpvdJNqbD https://t.co/6ojKMCqdDi
-
-
Mashup Score: 5Presidential Select Symposium explores complex challenges of cancer care during pregnancy - AACR Annual Meeting News - 2 year(s) ago
A group of distinguished experts joined AACR Past President Lisa M. Coussens, PhD, FAACR, to discuss several complications of treating pregnant cancer patients, from the lack of randomized data about the safety and efficacy of cancer treatment in pregnant women to the increasingly complicated landscape of reproductive rights in the U.S.
Source: AACR Annual Meeting NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Pregnancy and Cancer: Virginia F. Borges, Brandon M. Hayes-Lattin, @coussens_lisa, @AnnPartridgeMD, and @itsnot_pink addressed this critical topic during the Presidential Select Symposium at #AACR23. Read a recap in AACR Annual Meeting News: https://t.co/D3vofyLCD1 https://t.co/xyXENDBlzc
-
-
Mashup Score: 1Annual Meeting highlights showcased in final plenary session - AACR Annual Meeting News - 2 year(s) ago
During the final session of the AACR Annual Meeting 2023, Program Committee Chair Robert H. Vonderheide, MD, DPhil, and three members of the Program Committee reviewed several significant highlights and important themes from the meeting.
Source: AACR Annual Meeting NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#AACR23 Vision for the Future: Robert H. Vonderheide, Shivaani Kummar, Elizabeth A. Platz, and @sastewartlab presented highlights from the AACR Annual Meeting 2023 and looked ahead during a closing plenary session. Read a recap in AACR Annual Meeting News: https://t.co/NyKuPQZ8pm https://t.co/DFTsYiIt66
-
-
Mashup Score: 2Researchers working on novel strategies to improve radiation therapy - AACR Annual Meeting News - 2 year(s) ago
During a Monday symposium, three researchers, including Quynh-Thu Le, MD, explored the potential of novel strategies to enhance the efficacy of radiation therapy in solid cancer at the individual level, and how these emerging therapies could help clinicians address the challenge of predicting therapeutic response.
Source: AACR Annual Meeting NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
During an @AACR symposium, SCI member @Qle_stanford reported that anti-Gal-1 treatment could enhance T-cell infiltration and improve response to anti-PD-1 therapy. #AACR24 https://t.co/4s8geIBinZ #RadiationTherapy https://t.co/dkVb63lCre
-
-
Mashup Score: 5Researchers working on novel strategies to improve radiation therapy - AACR Annual Meeting News - 2 year(s) ago
During a Monday symposium, three researchers, including Quynh-Thu Le, MD, explored the potential of novel strategies to enhance the efficacy of radiation therapy in solid cancer at the individual level, and how these emerging therapies could help clinicians address the challenge of predicting therapeutic response.
Source: AACR Annual Meeting NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Radiation Therapy, DNA Damage, and Immune Response — @bradwouters, @Qle_stanford, and @ranjitbindra presented Monday at #AACR23. Read a recap in AACR Annual Meeting News: https://t.co/OBzdR5JsF8 https://t.co/cN65QR3fAI
-
Electronic Health Records and Cancer Learning Health Systems — @DrMiaLevy; Michael Hassett, and Tina Hernandez-Boussard addressed this topic in a symposium at #AACR23. Read a recap in AACR Annual Meeting News: https://t.co/U7ITcEDL2A https://t.co/zQzWWLwopd